Outcomes of 43 small breed dogs treated for splenic hemangiosarcoma.

Abstract

OBJECTIVE: To determine outcome and prognostic factors in small breed dogs in which hemangiosarcoma was diagnosed and whether outcomes differed between small and large breed dogs with splenic hemangiosarcoma. STUDY DESIGN: Bi-institutional retrospective study. ANIMALS: Forty-three small breed (<20&#x2009;kg) and 94 large breed client-owned dogs. METHODS: Medical records were reviewed to identify dogs treated with splenectomy for splenic hemangiosarcoma. Data acquired included signalment, preoperative staging, bloodwork results, surgical findings, histopathologic findings, administration of chemotherapy, presence/absence of metastatic disease, and survival time (ST). Cox proportional hazards regression analysis was performed to assess prognostic factors associated with survival. RESULTS: The overall median ST was 116&#x2009;days and 97&#x2009;days for small and large breed dogs, respectively. The ST for dogs treated with surgery and chemotherapy was 207 and 139&#x2009;days for small and large breed dogs, respectively. The disease-free interval (DFI) was 446 and 80&#x2009;days for small and large breed dogs, respectively. Dog size was associated with DFI (P = .02) but not with ST (P = .09). The presence of metastasis at diagnosis was associated with decreased ST in small (P = .03) and large (P = .0009) breed dogs. Administration of chemotherapy (P = .02) was associated with increased ST (P = .02) in small breed dogs. CONCLUSION: The ST was not different in small and large breed dogs with splenic hemangiosarcoma treated with splenectomy and chemotherapy. CLINICAL SIGNIFICANCE: Prognosis remains poor despite aggressive therapies in small and large breed dogs.